Sorafenib (Ligesitai) 200mg*60's | Jiangxi Shanxiang China Generic | GLT

Generic Information: Ligesitai (China)

Ligesitai (利格司他) is a domestic Chinese generic of sorafenib manufactured by Jiangxi Shanxiang Pharmaceutical Co., Ltd. Each tablet delivers 200 mg of sorafenib tosylate, with 60 tablets per box. The product has passed China's generic-quality consistency evaluation, making it therapeutically equivalent to the originator Nexavar while being considerably more affordable.

What Is Ligesitai Used For?

Ligesitai is indicated for unresectable hepatocellular carcinoma, advanced renal cell carcinoma, and radioactive-iodine-refractory differentiated thyroid carcinoma. It serves as a first-line oral targeted therapy for advanced liver cancer and a standard option for advanced kidney cancer.

How Does Sorafenib (Ligesitai) Work?

Ligesitai works by inhibiting CRAF/BRAF and the receptor tyrosine kinases VEGFR-2/3, PDGFR-beta, c-Kit and FLT3. This multi-target action suppresses tumour-cell proliferation and blocks the formation of tumour-feeding blood vessels, thereby slowing disease progression.

Indications

The approved indications are unresectable HCC, advanced RCC, and radioiodine-refractory DTC. Treatment should be supervised by an oncology specialist with regular follow-up.

Dosage

The standard dose is 400 mg twice daily (800 mg per day), taken at least one hour before or two hours after food. One 60-tablet box lasts roughly 15 days at this dose. Stepwise dose reductions are applied when side effects occur.

Side Effects

Common side effects include hand-foot skin reaction, diarrhoea, fatigue, rash, hypertension, nausea and hair thinning. Serious but rare effects are liver toxicity, bleeding, cardiac events and gastrointestinal perforation. Blood pressure, liver function and blood counts should be checked regularly.

Storage

Keep the tablets at room temperature in a dry, dark place, in the original packaging, out of reach of children, and discard after the expiry date.

Why Choose the GLT?

Ligesitai offers sorafenib at a domestic-China price point that is far below Western list prices for the originator. For patients and institutions who need to continue therapy over many months, this consistency-evaluated generic dramatically reduces the cost of care while preserving the efficacy of the original molecule.

How to Order

To order Ligesitai, message GLT on WhatsApp at +86 15234153837 or email [email protected]. We confirm availability, price and shipping from our Hong Kong-licensed facility before you commit.

FAQ

Who makes Ligesitai? Ligesitai is made by Jiangxi Shanxiang Pharmaceutical Co., Ltd., a Chinese pharmaceutical manufacturer.

Is Ligesitai a generic of Nexavar? Yes, it is a generic containing the same sorafenib active ingredient, approved for the same indications.

What is the price advantage? As a domestic generic, Ligesitai is substantially cheaper than originator sorafenib, easing the long-term cost of treatment.